Philip Minotti, MD
Adult Reconstructive Orthopaedic Surgery · Branford, CTNPI 1346237500
Payments from drug & device makers
What this record shows
Stryker accounts for 87.9% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2020 at $2,921 and has fallen 90.2% since, to $285 in 2025.
Across 78 payments — averaging $62.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$4K
- Amgen$368
- Johnson & Johnson$73
- CSL Behring$62
- Merck$23
- Pacira Pharmaceuticals Incorporated$21
- plus $47 from 3 others
What the payments were for
- Travel & lodging$2,55452%
- Food & beverage$2,35648%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 23 | $4,317 |
| Amgen | 45 | $368 |
| Johnson & Johnson(2 entities) | 3 | $73 |
| CSL Behring | 2 | $62 |
| Merck | 1 | $23 |
| Pacira Pharmaceuticals Incorporated | 1 | $21 |
| Globus Medical | 1 | $17 |
| Bioventus LLC | 1 | $16 |
| Pfizer | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few adult reconstructive orthopaedic surgery providers in Connecticutto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Meloxicam | 334 | $785 |
| Amoxicillin | 294 | $521 |
| Oxycodone Hcl | 79 | $436 |
| Diclofenac Sodium | 50 | $291 |
| Clindamycin Hcl | 63 | $280 |
| Celecoxib | 23 | $278 |
| Tramadol Hcl | 81 | $215 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 12 | $92 |
| Methylprednisolone | 16 | $83 |
Paid to pharmacies, not to this prescriber.
Other adult reconstructive orthopaedic surgery in Branford
- Christopher LynchBranford$48K
- Jenna BernsteinTrumbull$273K
- Paul MurrayHartford$64K
- Thomas HickernellStamford$45K
- Arthur ManoliWilton$25K
- Elie MansourNew Haven$24K
- Ryan CharetteWallingford$16K
- Derek ShiaHamden$7K
- Donald AllenHartford$7K
- Adam GreenNorth Franklin$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.